Diego Muñoz

Dr. Diego Muñoz

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2022 in Pharmacological Research
Verified
Journal Article
Closed access
EPErika Plazas
Erika Plazas
Mónica Avila-MurilloMónica Avila-Murillo
Mónica Avila-Murillo
DMDiego Muñoz
Diego Muñoz
LELUIS ENRIQUE
LUIS ENRIQUE

18 August 2010 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
JGJuan David Guzman
Juan David Guzman
AGAntima Gupta
Antima Gupta
DEDimitrios Evangelopoulos
Dimitrios Evangelopoulos
CBChandrakala Basavannacharya
Chandrakala Basavannacharya
Ludy Cristina Pabón-BaqueroLudy Cristina Pabón-Baquero
Ludy Cristina Pabón-Baquero
Sanjib BhaktaSanjib Bhakta
Sanjib Bhakta
New anti-mycobacterial entities with novel mechanisms of action are clinically needed for treating resistant forms of tuberculosis. The purpose of this study was to evaluate anti-tubercular activity and selectivity of seven recently isolated natural products from Colombian plants. MICs were determined using a liquid medium growth inhibition assay for Mycobacterium tuberculosis H37Rv and both solid and liquid media growth inhibition assays for Mycobacterium bovis BCG. Escherichia coli growth inhibition and mammalian macrophage cell toxicity were evaluated to establish the degree of selectivity of the natural product against whole cell organisms. Enzymatic inhibition of ATP-dependent MurE ligase from M. tuberculosis was assayed using a colorimetric phosphate detection method. The most active compound, 3-methoxynordomesticine hydrochloride, was further investigated on M. bovis BCG for its inhibition of sigmoidal growth, acid-fast staining and viability counting analysis. Aporphine alkaloids were found to be potent inhibitors of slow-growing mycobacterial pathogens showing favourable selectivity and cytotoxicity. In terms of their endogenous action, the aporphine alkaloids were found inhibitory to M. tuberculosis ATP-dependent MurE ligase at micromolar concentrations. A significantly low MIC was detected for 3-methoxynordomesticine hydrochloride against both M. bovis BCG and M. tuberculosis H37Rv. Considering all the data, 3-methoxynordomesticine hydrochloride was found to be a potent anti-tubercular compound with a favourable specificity profile. The alkaloid showed MurE inhibition and is considered an initial hit for exploring related chemical space.

5 April 2012 in Molecules
Verified
Journal Article
Open access
PDF file
Luis Eduardo DiazLuis Eduardo Diaz
Luis Eduardo Diaz
DMDiego Muñoz
Diego Muñoz
RPRosa E. Prieto
Rosa E. Prieto
SCSergio A. Cuervo
Sergio A. Cuervo
DGDiego L. Gonzalez
Diego L. Gonzalez
Sanjib BhaktaSanjib Bhakta
Sanjib Bhakta
Phenolic compounds are widely distributed in Nature and act as pharmacologically active constituents in many herbal medicines. They have multiple biological properties, most notably antioxidant, antibacterial and cytotoxic activities. In the present study an attempt to correlate the phenolic composition of leaf, flower and wood extracts of Piper imperiale, with antioxidant, antitubercular and cytotoxic activities was undertaken. The total phenol content ranged from 1.98 to 6.94 mg GAE/gDW among ethanolic extracts, and gallic acid, catechin, epicatechin, ferulic acid, resveratrol and quercetin were identified and quantified by HPLC. DPPH and ABTS assays showed high antioxidant activity of the leaf extract (EC50ABTS = 15.6 µg/mL, EC50DPPH = 27.3 µg/mL) with EC50 in the same order of magnitude as the hydroxyquinone (EC50ABTS = 10.2 µg/mL, EC50DPPH = 15.7 µg/mL). The flower extract showed strong antimicrobial activity against Mycobacterium tuberculosis H37Rv. All the extracts exhibited dose-dependent cytotoxic effects against MCF-7 cancer cells. This is the first time that a Piper extract has been found to be highly active against M. tuberculosis. This study shows the biological potential of Piper imperiale extracts and gives way to bio-guided studies with well-defined biological activities.

9 September 2019 in Cancers
Verified
Journal Article
Open access
PDF file
DMDiego Muñoz
Diego Muñoz
MBMartina Brucoli
Martina Brucoli
SZSilvia Zecchini
Silvia Zecchini
ASAdrian Sandoval-Hernandez
Adrian Sandoval-Hernandez
GAGonzalo Arboleda
Gonzalo Arboleda
DCDavide Cervia
Davide Cervia
X-linked inhibitor of apoptosis protein (XIAP) is an emerging crucial therapeutic target in cancer. We report on the discovery and characterisation of small organic molecules from Piper genus plants exhibiting XIAP antagonism, namely erioquinol, a quinol substituted in the 4-position with an alkenyl group and the alkenylphenols eriopodols A–C. Another isolated compound was originally identified as gibbilimbol B. Erioquinol was the most potent inhibitor of human cancer cell viability when compared with gibbilimbol B and eriopodol A was listed as intermediate. Gibbilimbol B and eriopodol A induced apoptosis through mitochondrial permeabilisation and caspase activation while erioquinol acted on cell fate via caspase-independent/non-apoptotic mechanisms, likely involving mitochondrial dysfunctions and aberrant generation of reactive oxygen species. In silico modelling and molecular approaches suggested that all molecules inhibit XIAP by binding to XIAP-baculoviral IAP repeat domain. This demonstrates a novel aspect of XIAP as a key determinant of tumour control, at the molecular crossroad of caspase-dependent/independent cell death pathway and indicates molecular aspects to develop tumour-effective XIAP antagonists.

18 December 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SMSandra L. Molina
Sandra L. Molina
AFAbel M. Forero
Abel M. Forero
FAFarja I. Ayala
Farja I. Ayala
MPMónica Puyana
Mónica Puyana
SZSven Zea
Sven Zea
Freddy RamosFreddy Ramos
Freddy Ramos
The Caribbean soft coral Erythropodium caribaeorum is a rich source of erythrolides—chlorinated briarane diterpenoids. These compounds have an ecological role as feeding deterrents, with a wide variation in their composition depending on the location where the sample is collected. In Colombia, this soft coral can be found at different locations in the Caribbean Sea including Santa Marta, Islas del Rosario, and Providencia—three environmentally different coral reef areas in the south and southwest Caribbean Sea. In order to evaluate differences in erythrolide composition, the metabolic profiles of samples from each of these locations were analyzed by HPLC-MS. Principal component analysis showed changes in the diterpene composition according to the sample origin. Diterpenes from samples collected at each location were isolated to describe the three chemotypes. The chemotype from Santa Marta was highly diverse, with the new erythrolides W and X together with eight known erythrolides. The sample from Islas del Rosario showed a low diversity chemotype constituted by high amounts of erythrolide A and B. The chemotype from Providencia showed low chemical diversity with only two main compounds—erythrolide V and R. Evaluation of cytotoxic activity against the human cancer cell lines PC-3, MCF7, and A549 showed erythrolides A and B as the more active compounds with IC50 values in the range from 2.45 to 30 μM.

1 July 2016 in Revista Colombiana de Cancerología
Verified
Journal Article
Closed access
DMDiego Muñoz
Diego Muñoz
LSLuis Enrique Cuca Suárez
Luis Enrique Cuca Suárez